T2 Biosystems (FRA:3T2) Beginning Cash Position : €4.32 Mil (As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is T2 Biosystems Beginning Cash Position?

T2 Biosystems's Beginning Cash Position for the quarter that ended in Sep. 2024 was €4.32 Mil.

T2 Biosystems's quarterly Beginning Cash Position declined from Mar. 2024 (€14.94 Mil) to Jun. 2024 (€6.28 Mil) and declined from Jun. 2024 (€6.28 Mil) to Sep. 2024 (€4.32 Mil).

T2 Biosystems's annual Beginning Cash Position increased from Dec. 2021 (€15.35 Mil) to Dec. 2022 (€22.46 Mil) but then declined from Dec. 2022 (€22.46 Mil) to Dec. 2023 (€10.89 Mil).

T2 Biosystems Beginning Cash Position Historical Data

The historical data trend for T2 Biosystems's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

T2 Biosystems Beginning Cash Position Chart

T2 Biosystems Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

45.89

9.22

15.35

22.46

10.89

T2 Biosystems Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Beginning Cash Position	Get a 7-Day Free Trial															15.59	22.81	14.94	6.28	4.32

T2 Biosystems Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

T2 Biosystems Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of T2 Biosystems's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

T2 Biosystems Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » T2 Biosystems Inc (FRA:3T2) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

TTOO:USA 0A57:UK

Address

101 Hartwell Avenue, Lexington, MA, USA, 02421

Website

https://www.t2biosystems.com

T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.

T2 Biosystems Headlines

No Headlines